Bonanno L - Search Results

1

Pasello G, Fabricio ASC, Del Bianco P, Salizzato V, Favaretto A, Piccin L, Zustovich F, Fabozzi A, De Rossi C, Pigozzo J, De Nuzzo M, Cappelletto E, Bonanno L, Palleschi D, De Salvo GL, Guarneri V, Gion M, Chiarion-Sileni V. Pasello G, et al. Among authors: bonanno l. J Transl Med. 2024 Mar 5;22(1):242. doi: 10.1186/s12967-024-04920-6. J Transl Med. 2024. PMID: 38443899 Free PMC article.

2

Prognostic and predictive implications of EGFR mutations, EGFR copy number and KRAS mutations in advanced stage lung adenocarcinoma.

Bonanno L, Schiavon M, Nardo G, Bertorelle R, Bonaldi L, Galligioni A, Indraccolo S, Pasello G, Rea F, Favaretto A. Bonanno L, et al. Anticancer Res. 2010 Dec;30(12):5121-8. Anticancer Res. 2010. PMID: 21187500

3

Platinum-based doublet chemotherapy in pre-treated malignant pleural mesothelioma (MPM) patients: a mono-institutional experience.

Pasello G, Nicotra S, Marulli G, Rea F, Bonanno L, Carli P, Magro C, Jirillo A, Favaretto A. Pasello G, et al. Among authors: bonanno l. Lung Cancer. 2011 Sep;73(3):351-5. doi: 10.1016/j.lungcan.2011.01.005. Epub 2011 Feb 5. Lung Cancer. 2011. PMID: 21296448

4

Mechanisms of acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors and new therapeutic perspectives in non small cell lung cancer.

Bonanno L, Jirillo A, Favaretto A. Bonanno L, et al. Curr Drug Targets. 2011 Jun;12(6):922-33. doi: 10.2174/138945011795528958. Curr Drug Targets. 2011. PMID: 21443472 Review.

5

Role of genotyping in non-small cell lung cancer treatment: current status.

Bonanno L, Favaretto A, Rugge M, Taron M, Rosell R. Bonanno L, et al. Drugs. 2011 Dec 3;71(17):2231-46. doi: 10.2165/11597700-000000000-00000. Drugs. 2011. PMID: 22085382 Review.

6

A pathological complete response after preoperative chemotherapy with carboplatin and pemetrexed in malignant pleural mesothelioma: A case report.

Pasello G, Altavilla G, Bonanno L, Rea F, Favaretto AG. Pasello G, et al. Among authors: bonanno l. J Thorac Dis. 2010 Dec;2(4):254. doi: 10.3978/j.issn.2072-1439.2010.02.04.2. J Thorac Dis. 2010. PMID: 22263055 Free PMC article.

7

Pemetrexed plus carboplatin or cisplatin as neoadjuvant treatment of operable malignant pleural mesothelioma (MPM).

Pasello G, Marulli G, Polo V, Breda C, Bonanno L, Loreggian L, Rea F, Favaretto A. Pasello G, et al. Among authors: bonanno l. Anticancer Res. 2012 Dec;32(12):5393-9. Anticancer Res. 2012. PMID: 23225442

8

The predictive value of 53BP1 and BRCA1 mRNA expression in advanced non-small-cell lung cancer patients treated with first-line platinum-based chemotherapy.

Bonanno L, Costa C, Majem M, Sanchez JJ, Gimenez-Capitan A, Rodriguez I, Vergnenegre A, Massuti B, Favaretto A, Rugge M, Pallares C, Taron M, Rosell R. Bonanno L, et al. Oncotarget. 2013 Oct;4(10):1572-81. doi: 10.18632/oncotarget.1157. Oncotarget. 2013. PMID: 24197907 Free PMC article.

9

Platinum drugs and DNA repair mechanisms in lung cancer.

Bonanno L, Favaretto A, Rosell R. Bonanno L, et al. Anticancer Res. 2014 Jan;34(1):493-501. Anticancer Res. 2014. PMID: 24403507 Review.

10

Nondisruptive p53 mutations are associated with shorter survival in patients with advanced non-small cell lung cancer.

Molina-Vila MA, Bertran-Alamillo J, Gascó A, Mayo-de-las-Casas C, Sánchez-Ronco M, Pujantell-Pastor L, Bonanno L, Favaretto AG, Cardona AF, Vergnenègre A, Majem M, Massuti B, Morán T, Carcereny E, Viteri S, Rosell R. Molina-Vila MA, et al. Among authors: bonanno l. Clin Cancer Res. 2014 Sep 1;20(17):4647-59. doi: 10.1158/1078-0432.CCR-13-2391. Epub 2014 Apr 2. Clin Cancer Res. 2014. PMID: 24696321

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

298 results

Search Page

Filters